Journal of Neuropsychiatry · 1991 · 65 citations · 21 references
MedicineGeriatric MedicinePharmacologyGeriatric PharmacologyNeuropharmacologyPharmacodynamicsCholinergic PharmacologyMedication UseNeuromuscular Blocking AgentsAnticholinergic DrugsAntimuscarinic DrugsCentral Nervous System Anticholinergic EffectsMental Status ChangesMuscarinic AgonistsMuscarinic ReceptorsNeurocognitive Safety Of Medications
Adverse drug reactions among elderly patients pose a significant clinical problem. The authors used a serum radioreceptor assay [RRA] to quantify drug-induced muscarinic blockade in 34 randomly selected nursing home residents. A random intervention group and the nonintervention control subjects were then retested 4 weeks later. The reduction of serum antimuscarinic activity (as determined by RRA) did relate to changes on several measures of cognitive function. A calculated "antimuscarinic index" lost significance with the RRA following intervention and may have overestimated the impact of a dosage reduction.
21
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Assessment in Geriatric Psychopharmacology
S. Hynie · Neuropharmacology · 1986 · 499 citations
Neurochemical characteristics of early and late onset types of Alzheimer's disease.
Martin N. Rossor, L L Iversen, Gavin P. Reynolds et al. · BMJ · 1984 · 416 citations · Full text